The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Ginkgo Bioworks Holdings Inc’s stock clocked out at $8.25, down -1.32% from its previous closing price of $8.36. In other words, the price has decreased by -$1.32 from its previous closing price. On the day, 1.07 million shares were traded. DNA stock price reached its highest trading level at $8.41 during the session, while it also had its lowest trading level at $7.93.
Ratios:
To gain a deeper understanding of DNA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.62 and its Current Ratio is at 5.62. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.61.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 15 ’25 when Che Austin bought 99 shares for $8.41 per share.
Che Austin bought 99 shares of DNA for $829 on Apr 14 ’25. On Apr 11 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $7.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 478777216 and an Enterprise Value of 354702720. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.11 while its Price-to-Book (P/B) ratio in mrq is 0.59. Its current Enterprise Value per Revenue stands at 1.562 whereas that against EBITDA is -0.853.
Stock Price History:
The Beta on a monthly basis for DNA is 1.11, which has changed by -0.76347476 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, DNA has reached a high of $45.20, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is -7.29%, while the 200-Day Moving Average is calculated to be -12.62%.
Shares Statistics:
It appears that DNA traded 1.73M shares on average per day over the past three months and 1876840 shares per day over the past ten days. A total of 42.70M shares are outstanding, with a floating share count of 36.98M. Insiders hold about 32.80% of the company’s shares, while institutions hold 59.02% stake in the company. Shares short for DNA as of 1743379200 were 11395098 with a Short Ratio of 6.59, compared to 1740700800 on 9062852. Therefore, it implies a Short% of Shares Outstanding of 11395098 and a Short% of Float of 33.62.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
